Literature DB >> 17515863

Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation.

Vittoria Buccigrossi1, Giulio de Marco, Eugenia Bruzzese, Luigi Ombrato, Ileana Bracale, Gaetano Polito, Alfredo Guarino.   

Abstract

Human milk stimulates intestinal development through the effects of various moieties. Lactoferrin (LF) is a glycoprotein of human milk whose concentration is highest in colostrum decreasing in mature milk. LF promotes enterocyte growth in intestinal cell lines. We tested the hypothesis that LF induces a distinct effect on enterocyte proliferation and differentiation, depending on its concentration. We examined the dose-related effects by human-native LF (N-LF) in Caco-2 (human colon adenocarcinoma) cells. At high concentrations, N-LF stimulated cell proliferation in immature Caco-2 cells, as judged by 3H-thymidine incorporation. In contrast, sucrase and lactase activities were increased at low but not high LF concentrations and their mRNA were also increased, indicating a transcriptional effect. Because iron binds specific LF sites, we compared the potency of N-LF and iron-saturated LF (I-LF) and found the native form more potent. Finally, we tested the effects by bovine LF (bLF) in the same system and found the latter more potent than the human isoform in inducing cell growth and lactase expression. These results suggest that LF directly induces enterocyte growth and proliferation, depending on its concentration, thereby regulating the earlyx postnatal intestinal development. bLF could be added to infant formula as a growth factor in selected intestinal diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515863     DOI: 10.1203/pdr.0b013e3180332c8d

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  40 in total

1.  Apo- and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERK-signaling and cell proliferation in Caco-2 cells.

Authors:  Rulan Jiang; Veronica Lopez; Shannon L Kelleher; Bo Lönnerdal
Journal:  J Cell Physiol       Date:  2011-11       Impact factor: 6.384

2.  Randomized controlled trial of lactoferrin for prevention of sepsis in peruvian neonates less than 2500 g.

Authors:  Theresa J Ochoa; Jaime Zegarra; Luis Cam; Raul Llanos; Alonso Pezo; Karen Cruz; Alonso Zea-Vera; Cesar Cárcamo; Miguel Campos; Sicilia Bellomo
Journal:  Pediatr Infect Dis J       Date:  2015-06       Impact factor: 2.129

Review 3.  Lactoferrin and necrotizing enterocolitis.

Authors:  Michael P Sherman
Journal:  Clin Perinatol       Date:  2013-01-17       Impact factor: 3.430

Review 4.  Necrotizing enterocolitis: new insights into pathogenesis and mechanisms.

Authors:  Diego F Niño; Chhinder P Sodhi; David J Hackam
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-08-18       Impact factor: 46.802

5.  Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates.

Authors:  Mohan Pammi; Steven A Abrams
Journal:  Cochrane Database Syst Rev       Date:  2019-05-11

Review 6.  Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.

Authors:  Mohan Pammi; Gautham Suresh
Journal:  Cochrane Database Syst Rev       Date:  2017-06-28

7.  A role for antimicrobial peptides in intestinal microsporidiosis.

Authors:  G J Leitch; C Ceballos
Journal:  Parasitology       Date:  2008-12-12       Impact factor: 3.234

8.  TGF-β2, a protective intestinal cytokine, is abundant in maternal human milk and human-derived fortifiers but not in donor human milk.

Authors:  Aaron A Reeves; Marney C Johnson; Margarita M Vasquez; Akhil Maheshwari; Cynthia L Blanco
Journal:  Breastfeed Med       Date:  2013-07-19       Impact factor: 1.817

Review 9.  Human breast milk and the gastrointestinal innate immune system.

Authors:  Brett M Jakaitis; Patricia W Denning
Journal:  Clin Perinatol       Date:  2014-06       Impact factor: 3.430

10.  Isolated liver transplantation for treatment of liver failure secondary to intestinal failure.

Authors:  Maria Immacolata Spagnuolo; Eliana Ruberto; Alfredo Guarino
Journal:  Ital J Pediatr       Date:  2009-09-15       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.